甲磺酸培高利特结构式
|
常用名 | 甲磺酸培高利特 | 英文名 | Pergolide mesylate salt |
|---|---|---|---|---|
| CAS号 | 66104-23-2 | 分子量 | 410.594 | |
| 密度 | N/A | 沸点 | 491.3ºC at 760 mmHg | |
| 分子式 | C20H30N2O3S2 | 熔点 | 252-254°C | |
| MSDS | 中文版 美版 | 闪点 | 250.9ºC | |
| 符号 |
GHS06 |
信号词 | Danger |
甲磺酸培高利特用途Pergolide甲磺酸盐是有抗帕金森病特性的多巴胺受体激动剂。 |
| 中文名 | 甲磺酸培高利特 |
|---|---|
| 英文名 | pergolide mesylate |
| 中文别名 | 8Β-[(甲硫基)甲基]-6-丙基麦角灵甲基磺酸盐 | 苯磺酸贝他斯汀 |
| 英文别名 | 更多 |
| 描述 | Pergolide甲磺酸盐是有抗帕金森病特性的多巴胺受体激动剂。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 沸点 | 491.3ºC at 760 mmHg |
|---|---|
| 熔点 | 252-254°C |
| 分子式 | C20H30N2O3S2 |
| 分子量 | 410.594 |
| 闪点 | 250.9ºC |
| 精确质量 | 410.169769 |
| PSA | 107.08000 |
| LogP | 4.79380 |
| InChIKey | UWCVGPLTGZWHGS-ZORIOUSZSA-N |
| SMILES | CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21.CS(=O)(=O)O |
| 外观性状 | 白色至灰白色固体 |
| 储存条件 | 存放在密封容器内,并放在阴凉,干燥处。储存的地方必须远离氧化剂。-20ºC保存。 |
| 稳定性 | 远离氧化物。 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:5 4.可旋转化学键数量:4 5.互变异构体数量:无 6.拓扑分子极性表面积107 7.重原子数量:27 8.表面电荷:0 9.复杂度:480 10.同位素原子数量:0 11.确定原子立构中心数量:3 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
| 更多 | 1. 性状:固体。 2. 密度(g/mL,25/4℃):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):252-254 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,5.2kPa):未确定 7. 折射率:未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(kPa,25ºC):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 。 |
| 符号 |
GHS06 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H300 |
| 警示性声明 | Missing Phrase - N15.00950417 |
| 个人防护装备 | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| 危害码 (欧洲) | T+: Very toxic; |
| 风险声明 (欧洲) | R28 |
| 安全声明 (欧洲) | S28-S36/37-S45 |
| 危险品运输编码 | UN 1544 |
| RTECS号 | KE6345000 |
| 甲磺酸培高利特上游产品 5 | |
|---|---|
| 甲磺酸培高利特下游产品 0 | |
|
Induction of methionine sulfoxide reductase activity by pergolide, pergolide sulfoxide, and S-adenosyl-methionine in neuronal cells.
Neurosci. Lett. 533 , 86-9, (2013) The reduction of methionine sulfoxide in proteins is facilitated by the methionine sulfoxide reductase (Msr) system. The Msr reduction activity is important for protecting cells from oxidative stress ... |
|
|
Determination of pergolide in horse plasma by UPLC-MS/MS for pharmacokinetic applications.
J. Pharm. Biomed. Anal. 94 , 54-7, (2014) Pergolide, an ergot-derived dopamine D2 receptor agonist, is used extensively as an orally administered treatment for pituitary pars intermedia dysfunction (PPID) in horses. One of the barriers associ... |
|
|
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Intern. Med. 52(3) , 325-32, (2013) The long-term use of levodopa to treat Parkinson's disease (PD) is often limited by the development of motor complications (e.g., levodopa-induced dyskinesia, LID). We hypothesized that a non-ergot do... |
|
实验名称:Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay
来源:ChEMBL
靶标:N/A
External Id:CHEMBL1266185
|
|
实验名称:Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
来源:NCGC
External Id:SNCA-p-activity-luciferase
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
来源:824
External Id:CYP273
|
|
实验名称:Minimum effective dose (sc) to induce emesis in male or female Beagle dogs
来源:ChEMBL
靶标:Canis lupus familiaris
External Id:CHEMBL666835
|
|
实验名称:Increase the activity of the Burkholderia fixLJ 2-component system
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Burkholderia multivorans
External Id:HMS1625
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify pos...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
来源:NCGC
External Id:HERG01
|
|
实验名称:uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
来源:Burnham Center for Chemical Genomics
靶标:cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id:SBCCG-A764-CF-PAF-Primary-Assay
|
| Pergolide methanesulfonate salt |
| Ergoline |
| Pergolide mesilate |
| (6aR,9R,10aR)-9-[(methylsulfanyl)methyl]-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline methanesulfonate |
| (6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline,methanesulfonic acid |
| Celance |
| Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8β)-, methanesulfonate (1:1) |
| (8β)-8-[(methylsulfanyl)methyl]-6-propylergoline methanesulfonate |
| MFCD00153859 |
| UNII-55B9HQY616 |
| Permax |
| 8-b-((Methylthio)methyl)-6-propylergoline Methanesulfonate |
| Pergolide mesylate |
| Methansulfonsäure--(6aR,9R,10aR)-9-[(methylsulfanyl)methyl]-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]chinolin(1:1) |
| (8β)-8-[(Methylsulfanyl)methyl]-6-propylergoline methanesulfonate (1:1) |
| Pergolide mesylate salt |
| 8b-((Methylthio)methyl)-6-propylergoline Monomethanesulfonate |
| Pergolide methanesulfonate |
| Pergolide (mesylate) |